MDx STD 28 PCR tests are molecular diagnostic tests employed for the detection of sexually transmitted infections using polymerase chain reaction technology intended to identify the presence of DNA or RNA from sexually transmitted pathogens.This test is sensitive and can detect low target of the pathogens allowing for early detection. The panel can screen multiple STIs simultaneously and guide early intervention.

MDx STD 28 PCR includes: Chlamydia trachomatis (CT), Cytomegalovirus (CMV), Candida albicans (CA), Atopobium vaginae (AV), Mycoplasma genitalium (MG), Haemophilus ducreyi (HD), Candida dubliniensis (CD), Bacterial vaginosis– associated bacteria 2 (BVAB2), Mycoplasma hominis (MH), Herpes simplex virus type 1 (HSV1), Candida glabrata (CG), Bacteroides fragilis (BF), Neisseria gonorrhoeae (NG), Herpes simplex virus type 2 (HSV2), Candida krusei (CK), Gardnerella vaginalis (GV), Trichomonas vaginalis (TV), Lymphogranuloma venereum (LGV), Candida lusitaniae (CL), Lactobacillus spp. (Lacto), Ureaplasma parvum (UP), Treponema pallidum (TP), Candida parapsilosis (CP), egasphaera Type 1 (Mega1), Ureaplasma urealyticum (UU), Varicella-zoster virus (VZV), Candida tropicalis (CTp), Mobiluncus spp. (Mob)